Global Neuromyelitis Optica (Devic's Syndrome) Clinical Trials Market Research Report, H2 2021 Review - ResearchAndMarkets.com
DUBLIN, December 01, 2021--(BUSINESS WIRE)--The "Neuromyelitis Optica (Devic's Syndrome) - Global Clinical Trials Review, H2, 2021" clinical trials has been added to ResearchAndMarkets.com's offering.
The clinical trial report provides an overview of Neuromyelitis Optica (Devic's Syndrome) Clinical trials scenario.
This report provides top line data relating to the clinical trials on Neuromyelitis Optica (Devic's Syndrome) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
Key Topics Covered:
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Companies Mentioned
F. Hoffmann-La Roche Ltd
AstraZeneca Plc
The Lundbeck Foundation
Boston Pharmaceuticals Inc
Hbm Holdings Ltd
PPD Inc
Takeda Pharmaceutical Co Ltd
Yantai Rongchang Pharmaceutical Co Ltd
Bionure Farma SL
Pamplona Capital Management LLP
For more information about this clinical trials report visit https://www.researchandmarkets.com/r/i33f8e
View source version on businesswire.com: https://www.businesswire.com/news/home/20211201005969/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900